Tyrosine Kinase JAK Inhibitors Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By JAK Type (Baricitinib (Olumiant), Tofacitinib (Xeljanz), Upadacitinib (Rinvoq)); End User (Pharmaceutical companies, Private and Government research institutes, Academic Institutes, Healthcare facilities) , and Geography (North America, Europe, Asia Pacific, and South and Central America)